The main pharmacological effect of anti-heart failure drugs is to address heart failure caused by reduced or impaired myocardial contractile function.
NO. | PubChem ID | CAS Number | Molecular Name | Efficacy | Efficacy_Chinese |
---|---|---|---|---|---|
51 | 82227 | 7785-70-8 | (1R,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene | anti-heart failure | 抗心力衰竭 |
52 | 87839 | 18881-04-4 | (1S,2S,5S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol | anti-heart failure | 抗心力衰竭 |
53 | 92139 | 644-30-4 | 1-methyl-4-(6-methylhept-5-en-2-yl)benzene | anti-heart failure | 抗心力衰竭 |
54 | 98914 | 43043-74-9 | 5,8-dihydroxy-2-(4-methylpent-3-enyl)naphthalene-1,4-dione | anti-heart failure | 抗心力衰竭 |
55 | 99477 | 0 | 6-hydroxychromen-2-one | anti-heart failure | 抗心力衰竭 |
56 | 101810 | 631-01-6 | (4aR,5R,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-9-formyl-5,10-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | anti-heart failure | 抗心力衰竭 |
57 | 107526 | 0 | (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | anti-heart failure | 抗心力衰竭 |
58 | 107561 | 4573-50-6 | (6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-one | anti-heart failure | 抗心力衰竭 |
59 | 114850 | 0 | (1R,2R,9S,17S)-13-oxido-7-aza-13-azoniatetracyclo[7.7.1.02,7.013,17]heptadecan-6-one | anti-heart failure | 抗心力衰竭 |
60 | 114917 | 568-73-0 | 1,6-dimethylnaphtho[1,2-g][1]benzofuran-10,11-dione | anti-heart failure | 抗心力衰竭 |